Corpus Intelligence IC Memo — ORTHOCOLORADO HOSPITAL 2026-04-26 03:45 UTC
IC Memo — ORTHOCOLORADO HOSPITAL
Investment Committee Memorandum | CO | 48 beds | Grade C | EBITDA uplift $8.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ORTHOCOLORADO HOSPITAL

CCN 060124 | JEFFERSON, CO | 48 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ORTHOCOLORADO HOSPITAL is a 48-bed community hospital in JEFFERSON, CO with $110.2M in net patient revenue and a 33.1% operating margin. The hospital serves a payer mix of 31.5% Medicare, 0.0% Medicaid, and 68.5% commercial.

Thesis: Turnaround. Our ML models identify $8.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 33.1% to 40.5% (+736bps).

Net Revenue HCRIS$110.2M
Current EBITDA COMPUTED$36.5M
Operating Margin COMPUTED33.1%
Occupancy HCRIS12.3%
Revenue / Bed COMPUTED$2.3M
Net-to-Gross HCRIS24.4%
Distress Probability MLnan%

2. Market Context & Competitive Position

108
CO Hospitals
-3.6%
State Median Margin
51
Comparable Hospitals

CO has 108 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of 33.1% places it above the state median. Among 51 size-comparable peers (24-96 beds), the median margin is -4.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (24-96), prioritizing same-state peers. 51 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ORTHOCOLORADO HOSPITAL (Target)CO48$110.2M33.1%
VALLEY VIEW HOSPITALCO31$285.3M-3.1%
CENTURA MERCY HOSPITALCO73$270.4M10.0%
UCHEALTH HIGHLANDS RANCH HOSPICO93$235.2M-4.6%
COMMUNITY HOSPITALCO44$216.5M-5.5%
VAIL VALLEY MEDICAL CENTERCO54$214.4M-28.1%
UCHEALTH LONGS PEAK HOSPITALCO83$181.8M-1.7%
PLATTE VALLEY MEDICAL CENTERCO89$181.0M-12.3%
CENTURA CASTLE ROCK ADVENTIST CO89$171.0M8.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.3M+210bp18mo
Cost to Collect4.5%2.5%$2.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.3M+122bp9mo
Clean Claim Rate88.0%96.0%$71K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.3M
Cost to Collect
$2.2M
Denial Rate Reduction
$2.2M
A/R Days Reduction
$1.3M
Clean Claim Rate
$71K
Total EBITDA Uplift$8.1M
Current EBITDA$36.5M
+ RCM Uplift+$8.1M
Pro Forma EBITDA$44.6M
Current Margin33.1%
Pro Forma Margin40.5%
WC Released (1x)$4.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$56.2M$322.0M5.73x41.8%
Base (11x exit)10.0x11.0x$56.2M$372.5M6.63x46.0%
Bull Case9.0x11.0x$50.6M$417.5M8.26x52.5%
Bull (12x exit)9.0x12.0x$50.6M$470.4M9.30x56.2%
Bear Case11.0x10.0x$61.8M$263.2M4.26x33.6%
Bear (11x exit)11.0x11.0x$61.8M$309.6M5.01x38.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 12.3%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 51 hospitals with 24-96 beds
  • Same-state prioritization (n=52)
  • Comp margins: P25=-9.7% / P50=-4.1% / P75=1.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.